用户名: 密码: 验证码:
依达拉奉对重症急性胰腺炎大鼠肠黏膜屏障功能障碍的保护作用
详细信息    本馆镜像全文|  推荐本文 |  |   获取CNKI官网全文
摘要
目的:探讨应用依达拉奉对重症急性胰腺炎大鼠肠黏膜屏障功能损伤的保护作用及其机制,从而为临床防治重症急性胰腺炎肠黏膜屏障功能障碍提供参考依据。
     方法:60只清洁级SD大鼠随机分为正常组(Norm组)(n=6)、假手术组(Sham组)(n=18)、重症急性胰腺炎组(SAP组)(n=18)和依达拉奉治疗组(ED组)(n=18)。Norm组不做任何处理;Sham组在开腹后仅翻动胰腺后关腹;SAP组采用逆行十二指肠胰胆管注射5%牛黄胆酸钠溶液制备SAP大鼠模型;ED组模型制备成功后即刻经尾静脉注射3mg/kg的依达拉奉。分别在建模成功后6h、12h、24h采集血液、肠道、胰腺标本。检测各组不同时间点血浆二胺氧化酶(DAO),血淀粉酶,及肠道组织中的丙二醛(MDA),超氧化物歧化酶(SOD),细胞间黏附分子-1(ICAM-1)水平,并且光镜观察肠道及胰腺病理形态的改变。采用SPSS13.0统计软件。Kolmogorow-Smirnow法对各组数据进行正态性检验,符合正态分布则用均数±标准差(x±s)描述,用单因素方差分析(one-way ANOVA分析)行组间差异比较,若各组间差异有统计学意义,进一步用SNK法(q检验)进行两两间比较,采用Pearson相关分析方法进行相关分析。
     结果:1.Norm组与Sham组血浆DAO水平差别无统计学意义(P>0.05);SAP组大鼠术后6h,12h,24h血浆DAO浓度和血淀粉酶浓度均高于Norm组和Sham组(P<0.05);ED组血浆DAO浓度和血淀粉酶浓度较Norm组和Sham组升高(P<0.05),但较SAP组降低(P<0.05)。2.Norm组与Sham组肠道组织MDA,SOD水平差别无统计学意义(P>0.05);与Norm组及Sham组相比,SAP组MDA水平3个时间点依次升高(P<0.05);SOD活性3个时间点依次下降(P<0.05);ED组较SAP组MDA水平均明显降低,SOD活性明显升高(P<0.05)。3.Nrom组与Sham组肠道组织ICAM-1水平差别无统计学意义(P>0.05);与Nrom组及Sham组相比,SAP组肠道ICAM-1水平在3个时间点均明显升高(P<0.05);ED组肠道ICAM-1水平较SAP组下降(P<0.05),但仍高于Nrom组和Sham组(P<0.05)。4.SAP组肠道组织病理学改变包括绒毛,固有层脱落,裸露,黏膜下毛细血管充血;胰腺组织病理学改变包括严重的水肿,出血,坏死,炎症细胞浸润;Norm组和Sham组胰腺及肠道评分差别无统计学意义(P>0.05);SAP组肠道和胰腺组织损伤病理评分明显高于Nrom组和Sham组(P<0.05);ED组肠道组织损伤病理评分较SAP组无统计学意义(P>0.05),但仍高于Nrom组和Sham组(P<0.05);ED组胰腺组织损伤病理评分较SAP组低(P<0.05),但仍高于Nrom组和Sham组(P<0.05)。5.血浆DAO水平与肠道MDA水平呈明显正相关(P<0.01),与肠道SOD活性呈明显负相关(P<0.01);血浆DAO与肠道组织ICAM-1水平呈明显正相关(P<0.01)。
     结论:SAP早期即存在肠黏膜屏障功能障碍,依达拉奉对重症急性胰腺炎大鼠肠黏膜屏障功能损害具有保护作用,机制可能与下调氧自由基及细胞因子水平以及下调内皮细胞ICAM-1表达有关。
Objective:The study was designed to investigate the intestinal mucosa barrier function changes in rat with severe acute pancreatitis (SAP),and the intervention effect of edaravone injection and its mechanisms of protection on intestinal mucosa barrier function injury of SAP with the purpose of providing evidence for preventing and curing intestinal mucosa barrier function injury of SAP in clinical practice.
     Methods:A total of 60 healthy male Sprauge-Dawley(SD)rats were randomly divided into norm group(Norm),sham-operation group (Sham), SAP group (SAP), edaravone treated group(ED), and each with 18 rats except for norm group(with 6 rats).The latter three groups each had three subgroups at three points:6,12,24 hours.Rats with SAP were prepared with retrograde cholangiopancreatic duct infusion in 5%sodium taurocholate.The dynamic changes of the indexes of intestinal mucosa barrier function injury and pancreas injury were observed at various time points in each group,including the levels of plasma diamine oxidase(DAO) and serum amylase and malondialdehyde (MDA), superoxide dismutase (SOD), intercellular adhesion molecule-1(ICAM-1) in gut. Pathologic changes in pancreas and gut tissues were observed. Statistical analysis was done by SPSS 13.0 statistical software. Frequency distribution of data was examined by the Kolmogorov-Smirnov test.Data according with normal distribution was described with mean±standard deviation (x±s). One-way ANOVA was used to analyse the difference among groups.If the difference was statistically significant, further using SNK method(q test) to compare between groups. The test correlation uses Pearson analysis.
     Results:1.Changes of The levels of serum amylase and plasma DAO were not significantly different between Norm group and Sham group.The levels of serum amylase and plasma DAO concentration in SAP group were significantly higher at 6h,12h,24h postoperation than Nrom group and Sham group; The levels of serum amylase and plasma DAO concentration in ED group were lower than SAP group,but higher than Nrom group and Sham group;2.Changes of MDA concentration, SOD activity in intestine were not significantly different between Nrom group and Sham group; Compared with Nrom group and Sham group,The concentration of MDA increased in SAP group at 6h,12h,24h postoperation,but the activity of SOD significantly decreased. The concentration of MDA lower in ED group in all times than SAP group,but higher than Nrom group and Sham group; The activity of SOD was higher in ED group in all times than SAP group,but lower than Nrom group and Sham group.3.Changes of ICAM-1 concentration in intestine were not significantly different between Nrom group and Sham group (P>0.05);Compared with Nrom group and Sham group,The concentration of ICAM-1 significantly increased in SAP group at 6h,12h,24h postoperation; The concentration of ICAM-1 lower in ED group in all times than SAP group,but higher than Nrom group and Sham group.4. Pathologic changes of intestinal tissue in SAP rats included villusand lamina loss,exposed,submucosal vascular congestion and so on. Pathologic changes of pancreatic tissue in SAP rats included edema, bleeding,necrosis and inflammatory cells infiltration.No pathologic damage of pancreatic tissue and intestinal tissue were seen in Nrom group and Sham group;The pathologic damage of pancreatic tissue was alleviated evidently in ED group comparied with SAP group; No pathologic damage of intestinal tissue was seen in SAP group and ED group.5.There was positive correlation between the concentration of plasma DAO and MDA,but negtive correlation between the concentration of plasma DAO and the activity of SOD; There was positive correlation between the concentration of plasma DAO and ICAM-1.
     Conclusion:The function of intestinal mucosal barrier is damaged in the early phases of SAP.Edaravone can protect the damages of intestinal mucosa barrier function in SAP rats,probably through reducing free radicals,cytokines and the ICAM-1 expressing the endothelia cells.
引文
[1]中华医学会消化病学分会胰腺疾病学组.中国急性胰腺炎诊治指南(草案)[J].中华内科杂志,2004,43:236-238
    [2]廖家智,王家.美国急性胰腺炎临床指南(诊断部分)[J].临床内科杂志,2007,24(2):137-139
    [3]罗衡桂,丁应文等.重症急性胰腺炎的治疗[J].中国现代医学杂志,2002,14:59-60
    [4]James R.A,Skipworth Stephen P,Pereira,et al. Acute pancreatitis[J]. Current Opinion in Critical Care,2008,14:172-178
    [5]Yasuda T,Tskeyama Y,et al.Breakdown of intestinal mucosa via accelerated apoptosis increases intestinal permeability in experimental severe acute pancreatitis[J].J Surg Res,2006,135:18-26
    [6]褚启龙,杨克敌等.氧化应激与细胞凋亡关系的研究进展[J].卫生研究,2003,32(3):276-279
    [7]Ranganna K, Mathew OP,et al.Involvement of glutathione/glutathione S-transferase antioxidant system in butyrate-inhibited vascular smooth muscle cell proliferation[J]. FEBS J,2007,274:5962-5978
    [8]Burdo J, Schubert D,et al. Glutathione production is regulated via distinct pathways in stressed and non-stressed cortical neurons[J]. Brain Res,2008, 1189:12-22
    [9]王红禄,孙家邦等.肥大细胞膜稳定剂对大鼠重症急性胰腺炎肠组织保护作用的实验研究[J].中国现代普通外科进展,2006,9(2):92-95
    [10]Frossard JL,Salyja A,et al.The role of intercellular adhesion molecule-1 and neutrophils in acute pancreatitis and panreatitis-associated lung injury[J].Gastro Eterology,1999,116(3):694-701
    [11]张欣中,叶子等.急性胰腺炎患者肠道屏障保护和炎性反应调控的研究[J].中国微循环杂志,2008,20(2):186-188
    [12]Grotz MR,Deitch EA,et al.Intestinal cytokine response arter gut ischemia:role of gut barrier failure[J].Ann Surg,1999,226(4)478-486
    [13]Zhang JX,Dang SC,et al.Changes of gastric and inrestinal blood flow,serum phospholipase A2 and interleukin-lbeta in rats with acute necrotizing pancreatitis[J]. World J Gastroenterol,2005,11:3578-3581
    [14]Tomatsuri N, Yoshida N,et al.Edaravone,a newly developed radical scavenger,protects against ischemia-reperfusion injury of the small intestine in rats[J].Int Mol Med,2004,13(1):105-109
    [15]Mukojima K,Mishima S,et al.Protective Effects of Free Radical Scavenger Edaravone Against Xanthine Oxidase-Mediated Permeability Increases in Human Intestinal Epithelial Cell Monolayer[J] Journal of Burn Care & Research,2009,30(2):335-340
    [16]Mori T,Yamamoto H,et al.A free radical scavenger,edaravone (MCI-186), diminishes intestinal neutrophil lipid peroxidation and bacterial translocation in a rat hemorrhagic shock model[J].Crit Care Med,2005,33(5):1064-1069
    [17]Wang ZT, Yao YM, Xiao GX, Sheng ZY. Risk factors of development of gut-derived bacterial translocation in thermally injured rats[J].World J Gastroenterol,2004,10:1619-1624
    [18]冯友根.新型脑神经保护剂依达拉奉[N].中国医药报,2004-3-23(7)
    [19]林峥,李兴旺等.依达拉奉对肠部分缺血-再灌注损伤大鼠肠组织TNF-α和IL-6的影响[J].江西医药,2008,43(4):293-299
    [20]杨静,马力文等.肿瘤与机体抗氧化系统[J].肿瘤防治杂志,2004,11(3):324-327
    [21]李刚,陈海平等.中药保护急性胰腺炎大鼠肠黏膜屏障的系列研究之五[C].第九届全国中西医结合普通外科学术交流大会暨胆道胰腺疾病新进展学习班论文汇编,2005,350-353
    [22]Thompson JS,Lok GD,et al.The effect of the route of nutrient delivery on gut structure and diamine oxidase levels[J].JPEN,1997,11:28-32
    [23]Wang YL,Zheng YJ,et al.Effects of gut barrier dysfunction and NF-KB activation on aggravating mechanism of severe acute pancreatitis [J].Joural of Digestive Diseases,2009,10:30-40
    [24]崔培林,吕栋等.急性坏死性胰腺炎肠黏膜氧化应激损伤和HIF-1α的表达[J]. 世界华人消化杂志,2009,17(1):24-30.
    [25]Ruan P,Gong ZJ,et al.Changes of plasma D-lactate,diamine oxidase and endotoxin in patients with liver cirrhosis[J].HPDT INT,2004,3:58-61
    [26]Jin W,Wang HD,et al.Increased intestinal inflammatory response and gut barrier dysfunction in Nrf2-deficient mice after traumatic brain injury[J]. Cytokine,2008,44:135-140
    [27]Frijus C,Kappelle L,et al.Inflammatory cell adhesion molecules ischemic cerebrovascular disease[J].Srtoke,2002,33(8):2115-2122
    [28]李勇,来运刚等.重症急性胰腺炎大鼠肠黏膜ICAM-1表达与黏膜损伤的关系[J].基础医学与临床,2004,24(1):69-72
    [29]吕艺,盛志勇等.肠缺血再灌注大鼠小肠血管内皮细胞ICAM-1表达的变化及其肠损伤的关系[J].中华普通外科杂志,2000,15(3):145
    [30]Wang X,Sun Z,et al.Inhibition of platelet activating factor,intercellular adhesion molecule 1 and platelet endothelial cell adhesion molecule 1 reduces experimental pancreatitis-associated gut endothelial barrier dysfunction[J].Br J Surg,1999,86 (3):411-415
    [31]宋祖军,刘健等.依达拉奉对失血性休克后的肠屏障功能障碍的保护作用[J].中国急救医学,2007,27(3):243-245
    [32]Nakamoto N,Tada S,et al.A free radical scavenger,edaravone,attenuates steatosis and cell death via reducing inflammatory cytokine production in rat acute liver injury [J].Free radical reseach,2002,37(8):849-859
    [33]刘心萍.依达拉奉的临床应用研究进展[J].中国药业,2009,18(7):62-63
    [34]李检生,杨友松.新型自由基清除剂依达拉奉的脑保护作用[J].国际神经病学神经外科学杂志,2006,33(2):125-128
    [35]Yamawaki M,Sasaki N,et al.Protective effect of edaravone against hypoxia-reoxigenation injury in rabbit crdiomyocutes[J].Br J Pharmacol,2004,142: 618-626
    [1]中华医学会消化病学分会胰腺疾病学组.中国急性胰腺炎诊治指南(草案)[J].中华内科杂志,2004,43:236-238
    [2]廖家智,王家.美国急性胰腺炎临床指南(诊断部分)[J].临床内科杂志,2007,24(2):137-139
    [3]Gloor B, Muller CA, et al.pancreatitic infection in severe pancreat it is:the role of fungus and multiresistent organisms[J].Arch Surg,2001,136(5):592-596
    [4]Fritz S,Hackert T,et al.Bacterial translocation and infected pancreatic necrosis in acute necrotizing pancreatitis derives from small bowel rather than from colon[J].The American Journal of Surgery,2010,200(2):111-117
    [5]Kazantsew GB. Plasmid labeling confirms bacterial translocation in pancreatitis[J].Am J Surg,1994,167 (1):201-207
    [6]Schwarz M, Thomsen J, Meyer H, Buchler MW, Beger HG.Frequency and time course of pancreatic and extrapancreatic bacterial infection in experimental acute pancreatitis in rats[J]. Surgery,2000,127:427-432
    [7]Fritz S, Hackert T,et al.Bacterial translocation and infected pancreatic necrosis in acute necrotizing pancreatitis derives from small bowel rather than from colon[J].The American Journal of Surgery,2010,200:111-117
    [8]Aydin S,Ifilk T,et al. Does the 3-aminobenzamide effect on bacterial translocation affect experimental acute necrotizing pancreatitis? [J] Turk J Gastroenterol,2009,20(1):20-26
    [9]Ammori BJ, Leeder PC,et al. Early increase in intestinal permeability in patients with severe acute pancreatitis:correlation with endotoxemia, organ failure, and mortality[J]. Journal of Gastrointestinal Surgery,1999,3 (3):252-262
    [10]武金宝,王继德,张亚历.肠黏膜屏障研究进展[J].世界华人消化杂志,2003,11(5):619-623
    [11]Luiten EJ, Hop WC,et al.prognostic importance of gram-negative colonization preceding pancreatic infection in severe acute pancreatitis.Results of a controlled clinical trial of selective decontamination[J].Intensive Care Med,1998,24(5):438-45
    [12]罗旭颖,王红.重症急性胰腺炎中肠道免疫功能紊乱的研究进展[J].世界华人消化杂志,2009,17(2):169-173
    [13]丁凯,李维勤.重症急性胰腺炎病人的肠黏膜屏障功能障碍[J].肠外与肠内营养,2008,15(6):373-376
    [14]罗声政,王瑞兰.失血性休克与肠道屏障功能障碍[J].实用医学杂志,2010,26(3):509-510
    [15]Wang ZF, Pang CE,et al. Hemorheological change of acute necrotic pancreatitis and its significance[J]. Chin. J. Gen. Surg,2000,9(3):225
    [16]Zhang, J.X, Qu, J.G, Cheng, G.Z., Li, L, Wang, X.Q.Changes of intestinal blood flow and phospholipase A2,interleukin-1β in serum of rats with acute necrotic pancreatitis. Basic Med[J]. Sci. Clin,2003,23(5):556-558
    [17]Li Y, Zhou ZG, Zhang J, et al.Microcirculatory detection of Toll-like receptor 4 in rat pancreas and intestine[J].Clin Hemorheol Microcirc,2006,34(2);213
    [18]滕占庆,张东萍,曹建春.肠黏膜屏障功能研究进展[J].疑难病杂志,2007,6(3):184-186
    [19]杨武,肖华.肠屏障功能障碍发生机制与诊断治疗[J].实用儿科临床杂志,2007,22(19):1514-1518
    [20]Fukuyama. K., Iwakiri,.R.,et al.Apoptosis induced by ischemia-reperfusion and fasting in gastric mucosa compared to small intestinal mucosa in rats[J]. Dig. Dis. Sci,2001,46(3):545-549
    [21]Inoue K,Hirota M,et al.Further for endothelin as an important mediator of pancreatic and intestinal ischemia in severe acute pancreatitis[J]. Pancreas, 2003,26(3):218
    [22]许玲芬,郭静等.血小板活化因子引起肠上皮细胞屏障非凋亡依赖性的通透性增高[J].中国医科大学学报,2011,3(10):42-45
    [23]王丽杰,孙梅.血小板活化因子受体拮抗剂对内毒素血症幼年大鼠肠粘膜上皮细胞间连接蛋白的影响[J].中国危重病急救医学,2007,19(8):96-99
    [24]Ji L, Yuan Y.Z.,et al. NF-κB and acute pancreatitis[J]. Foreign Medicine Internal Medicine,2000,27(9):396-398
    [25]Dauphinee SM,Karsan A,et al.Lipopolysaccharide signaling in endothelial cells[J]J Reconstr Microsurg,2008,24(5)351-359
    [26]Wright, G, Singh, I,et al. Endotoxin stress-response in cardiomyocytes: NF-kappaB activation and tumor necrosis factor-alpha expression[J]. Am. J. Physiol. Heart Circ. Physiol,2002,282(3):872-879
    [27]草海军,陈李华.肠屏障功能障碍的研究现状与展望[J].国际消化病杂志,2007,27(6):436-437
    [28]文文,陈渝萍.重症急性胰腺炎与肠道屏障功能障碍和肠源性感染关系的研究进展[J].海南医学,2010,21(15):114-116
    [29]蒋晓云,钱立平.重症急性胰腺炎肠道屏障功能损伤机制研究进展[J].国际消化病杂志,2006,26(4):221-223
    [30]ShangZ.M, Wang B.N,et al.Significance of epithelial cell apoptosis in the gut mucosal barrier dysfunction in acute severe pancreatitis [J]. Chinese Critical Care Medicine,2000,12(7):354-356
    [31]Hollander D.The intestinal permeability barriena hypothesis as to its regulation and involvement in crohon's disease.Scand J Gastroenterol,1992,27:721-726
    [32]Schmidt J, Rattner D,et al.A better model of acute pancreatitis for evaluating therapy[J].Ann. Surg,1992,215(1):44-56
    [33]李永渝.肠道屏障功能障碍的病理生理机制[J].胃肠病学,2006,11(10):629-632
    [34]Exner R, Weingartmann G,et al. Glutamine deficiency renders human monoc-ytic cells more susceptible to specific apoptosis triggers[J]. Surgery,2002, 131(1):75-80
    [35]Li Z.L et al.Intestinal bacteria translocation and severesurgical cases[J]. Chin. J. Surg,1998,36(A00):11-12
    [36]张小平,夏萍等.谷氨酰胺对饥饿大鼠肠黏膜局部免疫功能的保护作用[J].山东医药,2005,32:24-25
    [37]彭曦,尤忠义等.谷氨酰胺保护严重烧伤病人肠粘膜屏障功能的研究[J].肠外与肠内营养,2001,8(4):205-207
    [38]赵元珍,高春芳等.谷氨酰胺胃肠外营养对放射性肠炎鼠小肠上皮细胞的增殖作用[J].实用医学杂志,2007,12:1493-1495
    [39]房林,薛崇德等.精氨酸对肠粘膜屏障功能的影响[J].华夏医学,2000,13(2):124-126
    [40]蒋小华,李宁等.精氨酸对短肠综合征大鼠肠道代偿的影响[J].中华实验外科杂志,2007,24(8):1024
    [41]Pinheiro VG,Ramos LM,et al.Intestinal permeability and malabsorption of rifampin and isoniazid in active pulmonary tuberculosis[J].Braz J Infect Dis, 2006,10(6):374-379
    [42]蔡元坤,秦新裕.D-乳酸与肠道屏障功能[J].国外医学:外科学分册,2004.6
    [43]Wu GH,Wang H,et al.Glutamine supplemented parenteral nutrition prevents intestinal ischemia-reperfusion injury in rats[J].World J Gastraenterol,2004,10 (17):2592-2594
    [44]张妮,朱保权等.危重症患儿血浆D-乳酸水平与二胺氧化酶活性与胃肠功能障碍关系研究[J].临床儿科杂志,2006,24(10)974-976
    [45]杨武,肖桦等.肠屏障功能障碍发生机制与诊断治疗[J].使用儿科临床杂志,2007,22(19):1514-1518
    [46]孙晓庆.创伤后肠道通透性改变血浆标志物D-乳酸的实验研究[J].中国危重病急救医学,2000,12(8):476-478
    [47]刘晓昌,梅俏等。肠黏膜屏障功能监测研究进展[J].山东医药,2009,49(17):106-107
    [48]赵海东,田晓峰等.肠型脂肪酸结合蛋白对肠缺血早期诊断的意义[J].中国普通外科杂志,2004,13(7):513-516
    [49]肠黏膜屏障功能评价指标的检测和应用[J].医学综述,2010,16(4):623-625
    [50]Chiu CJ,Scott HJ,er al.Intestinal lesion in low-flow states.LA morphological, hemodynamic,and metabolic reappraisal [J].Arch Surg,1970,101(4):478-483
    [51]Haglund U,Osterberg J.Local consequences of reperfusion in the gut.Pierce A and Robert T Mathie:Ischemia-Reperfusion Injury[J].Blackwell Science,1999, 23(2):65-69

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700